Literature DB >> 8323475

Levodopa improves spatial contrast sensitivity in Parkinson's disease.

J T Hutton1, J L Morris, J W Elias.   

Abstract

OBJECTIVE: To study the effect of levodopa on the visual contrast sensitivity of patients with Parkinson's disease.
DESIGN: Contrast sensitivity of patients was measured before and after levodopa administration. Patient contrast sensitivity was compared with that of normal controls by repeated-measures analyses of variance.
SETTING: Parkinson's disease research center associated with private neurology practice. PATIENTS: Fifteen patients with idiopathic Parkinson's disease (eight men, seven women; mean age, 71.8 years) and 22 normal controls (10 men, 12 women; mean age, 68.0 years) volunteered for the study. INTERVENTION: Levodopa/carbidopa (Sinemet). MAIN OUTCOME MEASURE: Change in contrast sensitivity of parkinsonian patients.
RESULTS: Following levodopa treatment, the contrast sensitivity of parkinsonian patients improved significantly at the three lowest spatial frequencies tested (0.4, 1, and 2 cycles per degree).
CONCLUSIONS: Levodopa improves low-frequency contrast sensitivity in parkinsonian patients. Initially deficient contrast sensitivity in such patients may be restored to near normal levels by levodopa therapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8323475     DOI: 10.1001/archneur.1993.00540070041012

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  14 in total

Review 1.  Prefrontal Contributions to Attention and Working Memory.

Authors:  Zahra Bahmani; Kelsey Clark; Yaser Merrikhi; Adrienne Mueller; Warren Pettine; M Isabel Vanegas; Tirin Moore; Behrad Noudoost
Journal:  Curr Top Behav Neurosci       Date:  2019

2.  An overview of the visual dysfunctions in Parkinson's disease - Update from a prospective study in Transylvania.

Authors:  Vlad-Ioan Suciu; Corina-Iuliana Suciu; Simona Delia Nicoară; Lăcrămioara Perju-Dumbravă
Journal:  Rom J Ophthalmol       Date:  2022 Apr-Jun

Review 3.  Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease.

Authors:  Jee-Young Lee; Antonio Martin-Bastida; Ane Murueta-Goyena; Iñigo Gabilondo; Nicolás Cuenca; Paola Piccini; Beomseok Jeon
Journal:  Nat Rev Neurol       Date:  2022-02-17       Impact factor: 44.711

Review 4.  An Eye on Movement Disorders.

Authors:  Duncan Wilson; Mark Hallett; Tim Anderson
Journal:  Mov Disord Clin Pract       Date:  2021-08-10

5.  REM sleep behaviour disorder and visuoperceptive dysfunction: a disorder of the ventral visual stream?

Authors:  Ana Marques; Kathy Dujardin; Muriel Boucart; Delphine Pins; Marie Delliaux; Luc Defebvre; Philippe Derambure; Christelle Monaca
Journal:  J Neurol       Date:  2009-09-30       Impact factor: 4.849

Review 6.  Retinopathy in Parkinson Disease.

Authors:  Ivan Bodis-Wollner
Journal:  J Neural Transm (Vienna)       Date:  2009-11       Impact factor: 3.575

Review 7.  Neuroprotective strategies for retinal disease.

Authors:  Machelle T Pardue; Rachael S Allen
Journal:  Prog Retin Eye Res       Date:  2018-02-23       Impact factor: 21.198

8.  Visual symptoms in Parkinson's disease.

Authors:  R A Armstrong
Journal:  Parkinsons Dis       Date:  2011-05-25

Review 9.  Past, present and future role of retinal imaging in neurodegenerative disease.

Authors:  Amir H Kashani; Samuel Asanad; Jane W Chan; Maxwell B Singer; Jiong Zhang; Mona Sharifi; Maziyar M Khansari; Farzan Abdolahi; Yonggang Shi; Alessandro Biffi; Helena Chui; John M Ringman
Journal:  Prog Retin Eye Res       Date:  2021-01-15       Impact factor: 19.704

10.  Driving under low-contrast visibility conditions in Parkinson disease.

Authors:  E Y Uc; M Rizzo; S W Anderson; E Dastrup; J D Sparks; J D Dawson
Journal:  Neurology       Date:  2009-10-06       Impact factor: 11.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.